8-K
Current Report
MoonLake Immunotherapeutics Filed Acc 0001213900-21-024220
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading ea140237-8k_helixacquisition.htm…